Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1430 of 6351
-
Quitting smoking may be easier when someone helps with life's other struggles — a trial puts the idea to the test
Disease control Recruiting nowBackground: The goal of this study is to address parental smoking and social adversity, which can present an obstacle for smoking cessation, in order to decrease childhood exposure to second-hand cigarette smoke. To address these factors, this study includes a smoking cessation i…
Sponsor: St. Justine's Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a sleep hormone help fight superbugs?
Disease control Not yet recruitingThis study evaluates whether adding melatonin to standard colistin therapy improves outcomes in patients with multidrug-resistant (MDR) Gram-negative bacterial infections. These infections are difficult to treat and are associated with high morbidity and mortality, particularly i…
Phase 3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for chronic hives? experimental drug lesigercept enters Mid-Stage trial
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of lesigercept in approximately 150 participants with CSU. By enrolling participants with an inadequate response to H1-antihistamines, including those previously treated with omalizumab, this study is expected to provide evidenc…
Phase 2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New heart valve repair device offers hope without surgery
Disease control Recruiting nowTo confirm the effectiveness and safety of the GeminiOne Transcatheter Mitral Valve Repair System for the treatment of severe, symptomatic mitral regurgitation.
Sponsor: Sierra Valve LLC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug zigakibart aims to slow kidney disease in IgA nephropathy patients
Disease control Recruiting nowThe purpose of the study is to assess the effect of zigakibart on IgA nephropathy (IgAN) disease progression.
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a simple chemical wash replace surgery for trapped lungs?
Disease control CompletedThe purpose of this study is to compare the clinical and radiological efficacy of chemical pleural adhesiolysis (using either intrapleural 3% hydrogen peroxide or intrapleural corticosteroids) versus mechanical pleural adhesiolysis (via medical thoracoscopy) in patients with non-…
Phase 2 • Sponsor: Delta University for Science and Technology • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Simple pill may keep bladder cancer at bay, new study hopes
Prevention Recruiting nowLow grade non-muscle-invasive bladder cancer (NMIBC) often recurs after treatment, requiring repeated surgeries, especially in older patients. These recurrences can cause complications, reduce quality of life, and increase healthcare costs. Currently, there is no well-tolerated p…
Phase 2 • Sponsor: Paul Toren • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Could stroke patients skip the hospital? new trial tests Home-Based care for seniors
Disease control Recruiting nowARTIFICE is a prospective, multicenter, randomized, controlled, exploratory non-inferiority trial evaluating whether an ambulatory stroke unit model (aSU) is non-inferior to conventional inpatient stroke unit care (SU) in patients aged 60 years or older with acute ischemic stroke…
Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a pill that blocks estrogen help fight rare uterine cancers?
Disease control Recruiting nowThis study is to evaluate the efficacy and safety of elacestrant, in participants with advanced estrogen receptor (ER)-positive uterine sarcomas. The name of the study drug involved in this research study is: -Elacestrant (a type of selective estrogen receptor degrader)
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Immune retraining: could CAR-Treg cells tame autoimmune disease?
Disease control Not yet recruitingThe study aims to investigate the safety, tolerability, and preliminary clinical efficacy of BEN301 Injection in patients with autoimmune diseases. In patients with autoimmune diseases, Treg cells are typically deficient or dysfunctional. CAR-Treg cell therapy represents a promi…
Early phase 1 • Sponsor: Beijing Boren Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for Alzheimer's psychosis: Long-Term drug trial underway
Symptom relief By invitation onlyML-007C-MA-222 is a 52-week, flexible-dose, open-label extension study designed to evaluate the long-term safety, tolerability, and effectiveness of ML007C-MA in participants with ADP who have completed the antecedent study (ie, Study ML-007C-MA-221).
Phase 2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a phone app save babies with sickle cell? 24,000 infants enrolled in uganda study
Diagnosis Recruiting nowA cluster randomized trial (CRT) of the novel sickle cell disease (SCD), M-health based SCD Information Management and Communication system SIMCS vs routine new born screening strategy in health care centres in Uganda to evaluate impact on access screening, coordination of care a…
Sponsor: Makerere University • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
Bubble cushions may boost balance in down syndrome
Symptom relief CompletedConducted as a quasi-experimental study. It involves 22 children aged 6-9 years, recruited from different special education schools, who will participate in supervised balance and weight-shifting exercises for 30-45 minutes, three times a week, over 8 weeks.. Exercises will inclu…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New shot aims to keep pericarditis Flare-Ups at bay
Disease control Recruiting nowThe primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapies to KPL-387 monotherapy in participants with well-controlled recurrent pericarditis on standard therapies.
Phase 2 • Sponsor: Kiniksa Pharmaceuticals International, plc • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Text alerts could save lungs: 27,000 smokers tested in landmark screening trial
Prevention Recruiting nowTo evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specificall…
Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
AI tailors brain zaps to ease Veterans' gulf war pain
Symptom relief Recruiting nowThe goal of this clinical trial is to create a machine learning algorithm to improve active repetitive transcranial magnetic stimulation (rTMS) treatments for veterans and/or active military personnel by alleviating Gulf War Illness related headaches and body pain (GWI-HAP). This…
Sponsor: Veterans Medical Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Second chance: could a repeat Clot-Buster save stroke patients?
Disease control Recruiting nowDespite being the standard pharmacological reperfusion therapy for acute ischemic stroke, intravenous thrombolysis is limited by suboptimal recanalization rates. Tenecteplase (TNK), a newer thrombolytic agent, offers practical advantages over alteplase, including single bolus adm…
Phase 2 • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a vaccine and a urine test tame HPV16?
Disease control Recruiting nowThe current study is an open-label, non-randomized, longitudinal exploratory trial using the licensed Gardasil 9 (9vHPV) vaccine in an off-label context to investigate biological and immunological outcomes in human papillomavirus type 16 (HPV16) positive women. Two doses of the l…
Phase 2 • Sponsor: Universiteit Antwerpen • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
AI learns to spot bladder cancer under blue light
Diagnosis Recruiting nowBlue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Unlike regular white light cystoscopy, blue light cystoscopy makes use of a drug that induces fluorescence under blue light…
Sponsor: Photocure • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Cancer drug could ease rare nerve disorder
Disease control Recruiting nowThe MAZINGA study is a multicenter, open-label, single-arm Phase IIA clinical trial designed to evaluate the efficacy, safety, and tolerability of zanubrutinib in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) antibody-associated demyelinating polyneuropathy. An…
Phase 2 • Sponsor: Azienda Ospedaliera di Padova • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC